Stockreport

Can-Fite Enters into Strategic Agreement with Univo Pharmaceuticals to Develop Cannabinoid-Based Pharmaceuticals and Assays

Can-Fite Biopharma Ltd Sponsored ADR (Israel)  (CANF) 
NASDAQ:AMEX Investor Relations: ir.canfite.com
PDF Cannabinoids bind to A3AR, the target of Can-Fite’s drugs Can-Fite’s unparalleled expertise in these targets will be utilized to develop new cannabis-based pharmaceutica [Read more]